Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 201

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 201
---
 effectiveness of the Certificate of Amendment implementing the reverse stock split and the increase in authorized shares of common stock of the Company. 8. Common Stock The Company is authorized under its articles of incorporation, as amended, to issue up to 500,000,000shares of common stock, par value $0.001 per share. Common Stock Issuance during the year ended December 31, 2023 On February 13, 2023, the Company issued 6,017shares of its common stock in connection with the February 2023 Public Offering. The Company received net cash proceeds of $14.0 million. From February 14, 2023 to April 6, 2023, the Company issued 699 shares of common stock in connection with notices of cash exercise for Class C Pre -FundedWarrants issued in connection with the February 2023 Public Offering with a total purchase price of $33.64. From March 13, 2023 to June 30, 2023, the Company issued 4,948 shares of common stock in connection with notices of alternative cashless exercise for the Class C Common Stock Warrants issued in connection with the February 2023 Public Offering. On April 18, 2023, the Company issued 8 shares of common stock in connection with vested Rollover RSU awards. Common Stock Issuance during the year ended December 31, 2024 On January 29, 2024, the Company issued 212 shares of common stock in connection with notices of alternative cashless exercise for the Class C Common Stock Warrants issued in connection with the February 2023 Public Offering. On February 5, 2024, the Company issued 8,029 shares of its common stock in connection with the February 2024 Public Offering. The Company received net cash proceeds of $5.4 million. Between February 5, 2024 and February 13, 2024, the Company issued 77,282 shares of common stock in connection with notices of cash exercise for Class D Pre -FundedWarrants issued in connection with the February 2024 Public Offering with a total purchase price of $123.65. On June 11, 2024, as part of the Class D Warrant Inducement the Company issued 653 shares of its common stock to a third party consultant for services provided totaling $25,000. On August 22, 2024, the Company issued 6,312 shares